Ash Bullement
Impact in
- Economics and Econometrics top 10%
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Economic and Financial Impacts of Cancer
-
- Hemophilia Treatment and Research
- Multiple Myeloma Research and Treatments
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 23
- Economic and Financial Impacts of Cancer 5
- Pharmaceutical Economics and Policy 3
- Oncology 9
- Polyomavirus and related diseases 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Anthony J. Hatswell (14 shared papers)Gemma Shields (7 shared papers)Nicholas Latimer (4 shared papers)Mike Paulden (2 shared papers)Andrew Briggs (1 shared paper)Murtuza Bharmal (7 shared papers)Ronan Fougeray (2 shared papers)Jamie Elvidge (3 shared papers)
- Journals
- Value in Health (15 papers)PharmacoEconomics (8 papers)Journal of Medical Economics (3 papers)Applied Health Economics and Health Policy (3 papers)Future Oncology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Ash Bullement
43 papers receiving 440 citations
Peers
Comparison fields: 5 of 63
- Economics and Econometrics 125
- Hematology 38
- Oncology 81
- Statistics and Probability 18
- Hepatology 11
Countries citing papers authored by Ash Bullement
This map shows the geographic impact of Ash Bullement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ash Bullement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ash Bullement more than expected).
Fields of papers citing papers by Ash Bullement
This network shows the impact of papers produced by Ash Bullement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ash Bullement. The network helps show where Ash Bullement may publish in the future.
Co-authors
The 25 scholars most cited alongside Ash Bullement, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2018 | 53 | |
| 3 | 2019 | 41 | |
| 4 | 2020 | 36 | |
| 5 | 2017 | 25 | |
| 6 | 2018 | 22 | |
| 7 | 2019 | 19 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2016 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 12 | |
| 13 | 2022 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2021 | 8 | |
| 16 | 2019 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2021 | 6 | |
| 20 | 2017 | 5 |
About Ash Bullement
Ash Bullement is a scholar working on Economics and Econometrics, Oncology, Surgery, Hematology and Statistics and Probability, having authored 46 papers that have together received 449 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (23 papers), Economic and Financial Impacts of Cancer (5 papers), Polyomavirus and related diseases (4 papers), Statistical Methods in Clinical Trials (4 papers), Hemophilia Treatment and Research (3 papers), Pharmaceutical Economics and Policy (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Economics and Econometrics (125 citations), Hematology (38 citations), Oncology (81 citations), Statistics and Probability (18 citations) and Hepatology (11 citations). Ash Bullement has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anthony J. Hatswell, Gemma Shields, Nicholas Latimer, Mike Paulden, Andrew Briggs, Murtuza Bharmal, Ronan Fougeray, Jamie Elvidge, Dawn Lee and Michael Schlichting. Their work appears in journals such as Value in Health, PharmacoEconomics, Journal of Medical Economics, Applied Health Economics and Health Policy and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.